CRLconf 0.85

lamotrigine — CRL

$ETON · Eton Pharmaceuticals, Inc.

Event date

Date TBD

Sponsor runway

cash-flow +

$19.7M liquid

Evidence

“Eton was notified that its partner, Azurity Pharmaceuticals, received a Complete Response Letter from the U.S. Food and Drug Administration ("FDA") regarding the New Drug Application for the lamotrigine product candidate.”

Source: 8-K filed 2022-05-27View on EDGAR ↗0001493152-22-015359

Comparable historical crls· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

No insider Form 4 activity reported on $ETON in the 90 days around this event.

← All catalysts for $ETON